Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$472.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Isagro SpA's REMEDIER approved against esca disease complex


Friday, 20 Dec 2013 09:23am EST 

Isagro SpA:Says REMEDIER, a biological product based on Trichoderma asperellum (ICC012) and T. gamsii (ICC080), obtained the final authorization for its use on grapevine against Esca disease complex, a serious disease of grapevine.Says the authorization for use on grapevine follows the registration renewal for vegetable and ornamental crops till Apr. 30, 2019 (according to Reg. EU 540/2011).Says REMEDIER is already known for its control activity of diseases of the radicle apparatus of such crops. 

Company Quote

2.168
-0.054 -2.43%
24 Apr 2014